Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types

Siglec-9, a cell surface transmembrane receptor mainly expressed on B cells, CD56(+) NK cells, and CD4(+) and CD8(+) T cells, is strongly related to the tumor immune microenvironment. However, the expression pattern of Siglec-9 and its prognostic potential have not been investigated in a pan-cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuliang, Huang, Wei, Xie, Yutong, Wang, Chunyan, Luo, Ning, Chen, Yingying, Wang, Liefu, Cheng, Zhongping, Gao, Zhengliang, Liu, Shupeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968865/
https://www.ncbi.nlm.nih.gov/pubmed/35372497
http://dx.doi.org/10.3389/fmolb.2022.743515

Ejemplares similares

Ejemplares similares